Results 161 to 170 of about 308,666 (390)

Refractory heart failure due to acquired aortic coarctation after total arch replacement: find the right antidote!

open access: yesESC Heart Failure, EarlyView.
Abstract A 31‐year‐old male presented with unexplainable symptoms of heart failure including recurrent fatigue and orthopnoea after total arch replacement for type A aortic dissection 2 months ago. Computed tomography angiography detected a severe intra‐luminal stenosis, and we successfully implanted a balloon‐expandable stent to dilate the stenosis ...
Yi Xie, Chen Lu, Jia Hu
wiley   +1 more source

Clinical profile, short and long‐term outcomes of non‐ischaemic cardiogenic shock: A FRENSHOCK sub‐analysis

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Although predominant in routine practice, non‐ischaemic cardiogenic shock (NICS) remains underrepresented in past studies, mainly focused on ischaemic cardiogenic shock (CS). This study aims to describe the current NICS picture and define its independent correlates of short‐ and long‐term outcomes.
Miloud Cherbi   +20 more
wiley   +1 more source

Trametinib alters contractility of paediatric Noonan syndrome‐associated hypertrophic myocardial tissue slices

open access: yesESC Heart Failure, EarlyView.
Abstract Aims No curative treatment is available for RASopathy‐associated childhood‐onset hypertrophic cardiomyopathy (RAS‐CM). Preclinical data and individual reports suggest a beneficial effect of small molecules targeting the RAS–mitogen‐activated protein (MAP) kinase (MAPK) pathway in severely affected RAS‐CM patients.
Jules Hamers   +11 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

DIAGNOSIS AND TREATMENT OF HYPOTENSION DURING ANESTHESIA [PDF]

open access: bronze, 1953
C. R. STEPHEN, W K Nowill, R. C. Martin
openalex   +1 more source

Real‐world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Large‐scale, real‐world data on early initiation of sacubitril/valsartan in patients newly diagnosed (de novo) with HF with reduced ejection fraction (HFrEF) are limited. We examined the effectiveness of sacubitril/valsartan versus angiotensin‐converting enzyme inhibitor (ACEi)/angiotensin receptor blocker (ARB) on all‐cause and cause ...
Ankeet S. Bhatt   +6 more
wiley   +1 more source

Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus

open access: yesESC Heart Failure, EarlyView.
The HFFS is a new multidimensional tool for the identification of frailty in patients with HF developed through a Delphi process involving 54 international experts in the management of HF and frailty. Two versions of the HFFS have been developed after the third round of the Delphi process.
Cristiana Vitale   +60 more
wiley   +1 more source

Fluid Response Evaluation in Sepsis Hypotension and Shock

open access: yesChest, 2020
I. Douglas   +15 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy